Joshua E. Meyer, associate professor in the Department of Radiation Oncology at Fox Chase Cancer Center, has received a $422,368 grant to investigate the role of local consolidative therapy with radiation in the second-line treatment of metastatic colorectal cancer.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
